SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2188738

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2188738

AI In Breast Imaging Market Size, Share & Trends Analysis Report By Imaging Modality (Mammography, Breast MRI), By Application, By Clinical Use, By End Use, By Deployment, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 230 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

AI in Breast Imaging Market Summary

The global AI in breast imaging market size was valued at USD 305.9 million in 2025 and is projected to grow from USD 391.9 million in 2026 to USD 1,824.8 million by 2033, at a CAGR of 24.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.1% in 2025. The industry is driven by the increasing adoption of AI-assisted breast cancer screening and diagnosis, along with rising breast cancer incidence and screening volumes. Growing demand for radiologist workflow support and the expanding use of AI for cancer detection, breast density assessment, risk prediction, and diagnostic decision support are also driving the market.

AI-based solutions are being applied across mammography, digital breast tomosynthesis, breast ultrasound, and breast MRI for cancer detection and localization, lesion characterization, breast density assessment, risk prediction, image reconstruction, and workflow support. Recent clinical evidence is expanding the potential role of AI beyond basic detection. In July 2026, a study published in Radiology evaluated more than 577,000 screening mammograms across 109 U.S. imaging sites and found that integration of DeepHealth's AI-powered workflow increased the adjusted cancer detection rate among general radiologists by 32.7%, from 3.76 to 4.99 cancers per 1,000 examinations, reaching a level comparable to breast imaging specialists using the same workflow. AI applications are also expanding toward long-term risk assessment.

In September 2026, a study evaluated the IICM+ AI model for predicting distant breast cancer recurrence in patients with early-stage HR+/HER2-negative, node-negative disease. The model achieved a C-index of 0.735 compared with 0.578 for the 21-gene Recurrence Score in a separate validation group, although additional validation across larger and more diverse populations is required before routine clinical use. These developments are broadening the addressable application landscape toward cancer detection, diagnostic decision support, image-based risk prediction, and treatment monitoring. Regulatory clearances, clinical validation, digital imaging infrastructure, cloud-based deployment, and partnerships between AI developers and healthcare providers are further supporting market expansion.

Global AI in Breast Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends & opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in breast imaging market report based on imaging modality, application, clinical use, end use, deployment, and region:

  • Imaging Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Mammography
    • 2D Digital Mammography
    • Digital Breast Tomosynthesis
    • Contrast-Enhanced Mammography
  • Breast Ultrasound
    • Handheld Ultrasound
    • Automated Whole-Breast Ultrasound
  • Breast MRI
    • Conventional Contrast-Enhanced MRI
    • Abbreviated Breast MRI
  • Other Imaging Modalities
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cancer Detection and Localization
  • Lesion Characterization and Diagnostic Support
  • Breast Density Assessment
  • Image-Based Risk Prediction
  • Image Acquisition and Reconstruction
  • Workflow, Reporting, and Quality Assurance
  • Treatment Response Assessment
  • Clinical Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Routine Screening
  • Supplemental and High-Risk Screening
  • Diagnostic Evaluation
  • Staging and Treatment Monitoring
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Academic Medical Centers
  • Independent Breast and Women's Health Centers
  • Independent Diagnostic Imaging Centers
  • Government & Public Health Screening Programs
  • Deployment Outlook (Revenue, USD Million, 2021 - 2033)
  • On-Premise
  • Cloud-Based
  • Hybrid
  • Regional Outlook (Revenue, USD Million, 2021-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68041-066-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Imaging Modality
    • 1.1.2. Application
    • 1.1.3. Clinical Use
    • 1.1.4. End Use
    • 1.1.5. Deployment
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. AI in Breast Imaging Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing breast cancer screening volumes and earlier screening initiation
      • 3.2.1.2. Clinical evidence supporting AI-assisted mammography
      • 3.2.1.3. Growing demand for radiologist workload reduction
      • 3.2.1.4. Increasing adoption of AI-based breast density assessment
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Insufficient evidence for several supplemental screening applications
      • 3.2.2.2. Concerns regarding false positives, accountability, workflow integration, and implementation costs
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of AI-based breast cancer risk prediction
      • 3.2.3.2. AI-enabled breast density assessment and supplemental screening decision support
      • 3.2.3.3. Expansion from mammography into multimodality breast imaging
      • 3.2.3.4. Development of AI platforms supporting the complete breast-imaging workflow
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Regulatory, interoperability, cybersecurity, and clinical accountability requirements
      • 3.2.4.2. Balancing higher cancer detection with false-positive and recall management
  • 3.3. AI in Breast Imaging Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. AI in Breast Imaging Market: Imaging Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Breast Imaging Market: Imaging Modality Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global AI in Breast Imaging Market Size & Trend Analysis, by Imaging Modality, 2021 to 2033 (USD Million)
  • 4.4. Mammography
    • 4.4.1. Mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. 2D Digital Mammography
      • 4.4.2.1. 2D digital mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Digital Breast Tomosynthesis
      • 4.4.3.1. Digital breast tomosynthesis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Contrast-Enhanced Mammography
      • 4.4.4.1. Contrast-enhanced mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Breast Ultrasound
    • 4.5.1. Breast ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Handheld Ultrasound
      • 4.5.2.1. Handheld ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Automated Whole-Breast Ultrasound
      • 4.5.3.1. Automated whole-breast ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Breast MRI
    • 4.6.1. Breast MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Conventional Contrast-Enhanced MRI
      • 4.6.2.1. Conventional contrast-enhanced MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Abbreviated Breast MRI
      • 4.6.3.1. Abbreviated breast MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Other Imaging Modalities
    • 4.7.1. Other imaging modalities market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. AI in Breast Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Breast Imaging Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global AI in Breast Imaging Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Cancer Detection and Localization
    • 5.4.1. Cancer detection and localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Lesion Characterization and Diagnostic Support
    • 5.5.1. Lesion characterization and diagnostic support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Breast Density Assessment
    • 5.6.1. Breast density assessment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Image-Based Risk Prediction
    • 5.7.1. Image-based risk prediction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Image Acquisition and Reconstruction
    • 5.8.1. Image acquisition and reconstruction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. Workflow, Reporting, and Quality Assurance
    • 5.9.1. Workflow, reporting, and quality assurance market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Treatment Response Assessment
    • 5.10.1. Treatment response assessment market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. AI in Breast Imaging Market: Clinical Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Breast Imaging Market: Clinical Use Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global AI in Breast Imaging Market Size & Trend Analysis, by Clinical Use 2021 to 2033 (USD Million)
  • 6.4. Routine Screening
    • 6.4.1. Routine screening market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Supplemental and High-Risk Screening
    • 6.5.1. Supplemental and high-risk screening market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Diagnostic Evaluation
    • 6.6.1. Diagnostic evaluation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Staging and Treatment Monitoring
    • 6.7.1. Staging and treatment monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. AI in Breast Imaging Market: End-Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI in Breast Imaging Market: End-Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Global AI in Breast Imaging Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals & Academic Medical Centers
    • 7.4.1. Hospitals & academic medical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Independent Breast and Women's Health Centers
    • 7.5.1. Independent breast and women's health centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Independent Diagnostic Imaging Centers
    • 7.6.1. Independent diagnostic imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Government & Public Health Screening Programs
    • 7.7.1. Government & public health screening programs market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. AI in Breast Imaging Market: Deployment Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global AI in Breast Imaging Market: Deployment Movement Analysis, 2025 & 2033 (USD Million)
  • 8.3. Global AI in Breast Imaging Market Size & Trend Analysis, by Deployment 2021 to 2033 (USD Million)
  • 8.4. On-Premise
    • 8.4.1. On-premises market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Cloud-Based
    • 8.5.1. Cloud-based market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Hybrid
    • 8.6.1. Hybrid market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. AI in Breast Imaging Market: Regional Estimates & Trend Analysis By Imaging Modality, Application, Clinical Use, End Use, Deployment

  • 9.1. Regional Dashboard
  • 9.2. Market Size and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. North America AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. UK AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. Germany AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. France AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Italy AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Spain AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Denmark AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Competitive scenario
      • 9.4.9.3. Regulatory framework
      • 9.4.9.4. Reimbursement scenario
      • 9.4.9.5. Norway AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. China AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Japan
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. Japan AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. India AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. South Korea AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Australia AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Competitive scenario
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Reimbursement scenario
      • 9.5.7.5. Thailand AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Brazil AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. Reimbursement scenario
      • 9.6.3.5. Argentina AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. Middle East and Africa
    • 9.7.1. Middle East and Africa AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. South Africa AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. Saudi Arabia AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. UAE AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Competitive scenario
      • 9.7.5.3. Regulatory framework
      • 9.7.5.4. Reimbursement scenario
      • 9.7.5.5. Kuwait AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Market Share Analysis, 2025
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Technology Launches
    • 10.5.5. Research And Development
    • 10.5.6. Company Profiles
    • 10.5.7. Hologic
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Product benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. Lunit (incl. Volpara)
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Product benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. ScreenPoint Medical
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Product benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. DeepHealth (RadNet)
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Product benchmarking
      • 10.5.10.4. Strategic initiatives
    • 10.5.11. Therapixel
      • 10.5.11.1. Company overview
      • 10.5.11.2. Financial performance
      • 10.5.11.3. Product benchmarking
      • 10.5.11.4. Strategic initiatives
    • 10.5.12. Vara
      • 10.5.12.1. Company overview
      • 10.5.12.2. Financial performance
      • 10.5.12.3. Product benchmarking
      • 10.5.12.4. Strategic initiatives
    • 10.5.13. Siemens Healthineers
      • 10.5.13.1. Company overview
      • 10.5.13.2. Financial performance
      • 10.5.13.3. Product benchmarking
      • 10.5.13.4. Strategic initiatives
    • 10.5.14. GE HealthCare
      • 10.5.14.1. Company overview
      • 10.5.14.2. Financial performance
      • 10.5.14.3. Product benchmarking
      • 10.5.14.4. Strategic initiatives
    • 10.5.15. Clairity
      • 10.5.15.1. Company overview
      • 10.5.15.2. Financial performance
      • 10.5.15.3. Product benchmarking
      • 10.5.15.4. Strategic initiatives
    • 10.5.16. Koios Medical
      • 10.5.16.1. Company overview
      • 10.5.16.2. Financial performance
      • 10.5.16.3. Product benchmarking
      • 10.5.16.4. Strategic initiatives
    • 10.5.17. CureMetrix
      • 10.5.17.1. Company overview
      • 10.5.17.2. Financial performance
      • 10.5.17.3. Product benchmarking
      • 10.5.17.4. Strategic initiatives
    • 10.5.18. Densitas
      • 10.5.18.1. Company overview
      • 10.5.18.2. Financial performance
      • 10.5.18.3. Product benchmarking
      • 10.5.18.4. Strategic initiatives
    • 10.5.19. Whiterabbit.ai
      • 10.5.19.1. Company overview
      • 10.5.19.2. Financial performance
      • 10.5.19.3. Product benchmarking
      • 10.5.19.4. Strategic initiatives
    • 10.5.20. MedCognetics
      • 10.5.20.1. Company overview
      • 10.5.20.2. Financial performance
      • 10.5.20.3. Product benchmarking
      • 10.5.20.4. Strategic initiatives
    • 10.5.21. Philips
      • 10.5.21.1. Company overview
      • 10.5.21.2. Financial performance
      • 10.5.21.3. Product benchmarking
      • 10.5.21.4. Strategic initiatives
    • 10.5.22. Quibim
      • 10.5.22.1. Company overview
      • 10.5.22.2. Financial performance
      • 10.5.22.3. Product benchmarking
      • 10.5.22.4. Strategic initiatives
    • 10.5.23. QView Medical
      • 10.5.23.1. Company overview
      • 10.5.23.2. Financial performance
      • 10.5.23.3. Product benchmarking
      • 10.5.23.4. Strategic initiatives
    • 10.5.24. Qlarity Imaging
      • 10.5.24.1. Company overview
      • 10.5.24.2. Financial performance
      • 10.5.24.3. Product benchmarking
      • 10.5.24.4. Strategic initiatives
Product Code: GVR-4-68041-066-9

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 3 North America AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 4 North America AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 5 North America AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 6 North America AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 7 U.S. AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 8 U.S. AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 9 U.S. AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 10 U.S. AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 11 U.S. AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 12 Canada AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 13 Canada AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 14 Canada AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 15 Canada AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 16 Canada AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 17 Mexico AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 18 Mexico AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 19 Mexico AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 20 Mexico AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 21 Mexico AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 22 Europe AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 23 Europe AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 24 Europe AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 25 Europe AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 26 Europe AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 27 Germany AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 28 Germany AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 29 Germany AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 30 Germany AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 31 Germany AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 32 UK AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 33 UK AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 34 UK AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 35 UK AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 36 UK AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 37 France AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 38 France AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 39 France AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 40 France AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 41 France AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 42 Italy AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 43 Italy AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 44 Italy AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 45 Italy AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 46 Italy AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 47 Spain AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 48 Spain AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 49 Spain AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 50 Spain AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 51 Spain AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 52 Denmark AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 53 Denmark AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 54 Denmark AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 55 Denmark AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 56 Denmark AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 57 Sweden AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 58 Sweden AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 59 Sweden AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 60 Sweden AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 61 Sweden AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 62 Norway AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 63 Norway AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 64 Norway AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 65 Norway AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 66 Norway AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 67 Asia Pacific AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 68 Asia Pacific AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 69 Asia Pacific AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 70 Asia Pacific AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 71 Asia Pacific AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 72 China AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 73 China AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 74 China AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 75 China AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 76 China AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 77 India AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 78 India AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 79 India AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 80 India AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 81 India AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 82 Japan AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 83 Japan AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 84 Japan AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 85 Japan AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 86 Japan AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 87 Australia AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 88 Australia AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 89 Australia AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 90 Australia AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 91 Australia AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 92 South Korea AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 93 South Korea AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 94 South Korea AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 95 South Korea AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 96 South Korea AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 97 Thailand AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 98 Thailand AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 99 Thailand AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 100 Thailand AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 101 Thailand AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 102 Latin America AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 103 Latin America AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 104 Latin America AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 105 Latin America AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 106 Latin America AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 107 Brazil AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 108 Brazil AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 109 Brazil AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 110 Brazil AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 111 Brazil AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 112 Argentina AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 113 Argentina AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 114 Argentina AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 115 Argentina AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 116 Argentina AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 117 MEA AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 118 MEA AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 119 MEA AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 120 MEA AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 121 MEA AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 122 South Africa AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 123 South Africa AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 124 South Africa AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 125 South Africa AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 126 South Africa AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 127 Saudi Arabia AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 128 Saudi Arabia AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 129 Saudi Arabia AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 130 Saudi Arabia AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 131 Saudi Arabia AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 132 UAE AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 133 UAE AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 134 UAE AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 135 UAE AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 136 UAE AI in breast imaging market, by deployment, (USD Million) 2021-2033
  • Table 137 Kuwait AI in breast imaging market, by imaging modality, (USD Million) 2021-2033
  • Table 138 Kuwait AI in breast imaging market, by application, (USD Million) 2021-2033
  • Table 139 Kuwait AI in breast imaging market, by clinical use, (USD Million) 2021-2033
  • Table 140 Kuwait AI in breast imaging market, by end use, (USD Million) 2021-2033
  • Table 141 Kuwait AI in breast imaging market, by deployment, (USD Million) 2021-2033

List of Figures

  • Fig. 1 AI in breast imaging market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 AI in breast imaging market size and growth prospects (USD Million)
  • Fig. 11 AI in breast imaging market: Industry value chain analysis
  • Fig. 12 AI in breast imaging market: Market dynamics
  • Fig. 13 AI in breast imaging market: PORTER's analysis
  • Fig. 14 AI in breast imaging market: PESTEL analysis
  • Fig. 15 AI in breast imaging market share by imaging modality, 2025 & 2033 (USD Million)
  • Fig. 16 AI in breast imaging market, by imaging modality: market share, 2025 & 2033
  • Fig. 17 Mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 18 2D Digital mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 19 Digital breast tomosynthesis market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 20 Contrast-enhanced mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 21 Breast ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 22 Handheld ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 23 Automated whole-breast ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 24 Breast MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 25 Conventional contrast-enhanced MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 26 Abbreviated breast MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 27 Other imaging modalities market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 28 AI in breast imaging market share by application, 2025 & 2033 (USD Million)
  • Fig. 29 AI in breast imaging market, by application: market share, 2025 & 2033
  • Fig. 30 Cancer detection and localization market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 31 Lesion characterization and diagnostic support market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 32 Breast density assessment market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 33 Image-based risk prediction market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 34 Image acquisition and reconstruction market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 35 Workflow, reporting, and quality assurance market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 36 Treatment response assessment market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 37 AI in breast imaging market share by clinical use, 2025 & 2033 (USD Million)
  • Fig. 38 AI in breast imaging market, by clinical use: market share, 2025 & 2033
  • Fig. 39 Routine screening market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 40 Supplemental and high-risk screening market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 41 Diagnostic evaluation market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 42 Staging and treatment monitoring market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 43 AI in breast imaging market share by end use, 2025 & 2033 (USD Million)
  • Fig. 44 AI in breast imaging market, by end use: market share, 2025 & 2033
  • Fig. 45 Hospitals & academic medical centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 46 Independent breast and women's health centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 47 Independent diagnostic imaging centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 48 Government & public health screening programs market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 49 AI in breast imaging market share by deployment, 2025 & 2033 (USD Million)
  • Fig. 50 AI in breast imaging market, by deployment: market share, 2025 & 2033
  • Fig. 51 On-premises market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 52 Cloud-based market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 53 Hybrid market estimates & forecasts, 2021-2033 (Revenue, USD Million)
  • Fig. 54 Regional marketplace: key takeaways
  • Fig. 55 North America AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 56 U.S. AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 57 Canada AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 58 Mexico AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 59 Europe AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 60 UK AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 61 Germany AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 62 France AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 63 Italy AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 64 Spain AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 65 Sweden AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 66 Denmark AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 67 Norway AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 68 Asia Pacific AI in breast imaging market estimates and forecast, 2021 - 2033, (USD Million)
  • Fig. 69 China AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 70 Japan AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 71 India AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 72 South Korea AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 73 Australia AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 74 Thailand AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 75 Latin America AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 76 Brazil AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 77 Argentina AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 78 MEA AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 79 South Africa AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 80 Saudi Arabia AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 81 UAE AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 82 Kuwait AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
  • Fig. 83 Key company categorization
  • Fig. 84 Company market positioning
  • Fig. 85 Key company market share analysis, 2025
  • Fig. 86 Strategic framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!